Literature DB >> 8692929

The C-terminal domain of the largest subunit of RNA polymerase II interacts with a novel set of serine/arginine-rich proteins.

A Yuryev1, M Patturajan, Y Litingtung, R V Joshi, C Gentile, M Gebara, J L Corden.   

Abstract

Although transcription and pre-mRNA processing are colocalized in eukaryotic nuclei, molecules linking these processes have not previously been described. We have identified four novel rat proteins by their ability to interact with the repetitive C-terminal domain (CTD) of RNA polymerase II in a yeast two-hybrid assay. A yeast homolog of one of the rat proteins has also been shown to interact with the CTD. These CTD-binding proteins are all similar to the SR (serine/arginine-rich) family of proteins that have been shown to be involved in constitutive and regulated splicing. In addition to alternating Ser-Arg domains, these proteins each contain discrete N-terminal or C-terminal CTD-binding domains. We have identified SR-related proteins in a complex that can be immunoprecipitated from nuclear extracts with antibodies directed against RNA polymerase II. In addition, in vitro splicing is inhibited either by an antibody directed against the CTD or by wild-type but not mutant CTD peptides. Thus, these results suggest that the CTD and a set of CTD-binding proteins may act to physically and functionally link transcription and pre-mRNA processing.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8692929      PMCID: PMC38919          DOI: 10.1073/pnas.93.14.6975

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  48 in total

1.  Splice site selection, rate of splicing, and alternative splicing on nascent transcripts.

Authors:  A L Beyer; Y N Osheim
Journal:  Genes Dev       Date:  1988-06       Impact factor: 11.361

Review 2.  The superfamily of arginine/serine-rich splicing factors.

Authors:  X D Fu
Journal:  RNA       Date:  1995-09       Impact factor: 4.942

3.  Construction and analysis of yeast RNA polymerase II CTD deletion and substitution mutations.

Authors:  M L West; J L Corden
Journal:  Genetics       Date:  1995-08       Impact factor: 4.562

4.  Arc, a growth factor and activity-regulated gene, encodes a novel cytoskeleton-associated protein that is enriched in neuronal dendrites.

Authors:  G L Lyford; K Yamagata; W E Kaufmann; C A Barnes; L K Sanders; N G Copeland; D J Gilbert; N A Jenkins; A A Lanahan; P F Worley
Journal:  Neuron       Date:  1995-02       Impact factor: 17.173

5.  The photoactivated cross-linking of recombinant C-terminal domain to proteins in a HeLa cell transcription extract that comigrate with transcription factors IIE and IIF.

Authors:  M E Kang; M E Dahmus
Journal:  J Biol Chem       Date:  1995-10-06       Impact factor: 5.157

6.  Structural studies of a synthetic peptide derived from the carboxyl-terminal domain of RNA polymerase II.

Authors:  P M Cagas; J L Corden
Journal:  Proteins       Date:  1995-02

7.  New proteins related to the Ser-Arg family of splicing factors.

Authors:  B J Blencowe; R Issner; J Kim; P Mccaw; P A Sharp
Journal:  RNA       Date:  1995-10       Impact factor: 4.942

8.  Transcription-dependent redistribution of the large subunit of RNA polymerase II to discrete nuclear domains.

Authors:  D B Bregman; L Du; S van der Zee; S L Warren
Journal:  J Cell Biol       Date:  1995-04       Impact factor: 10.539

9.  A conserved epitope on a subset of SR proteins defines a larger family of Pre-mRNA splicing factors.

Authors:  K M Neugebauer; J A Stolk; M B Roth
Journal:  J Cell Biol       Date:  1995-05       Impact factor: 10.539

10.  The Drosophila SR protein RBP1 contributes to the regulation of doublesex alternative splicing by recognizing RBP1 RNA target sequences.

Authors:  V Heinrichs; B S Baker
Journal:  EMBO J       Date:  1995-08-15       Impact factor: 11.598

View more
  147 in total

Review 1.  Stress and the cell nucleus: dynamics of gene expression and structural reorganization.

Authors:  C Jolly; R I Morimoto
Journal:  Gene Expr       Date:  1999

2.  Topological localization of the carboxyl-terminal domain of RNA polymerase II in the initiation complex.

Authors:  M Douziech; D Forget; J Greenblatt; B Coulombe
Journal:  J Biol Chem       Date:  1999-07-09       Impact factor: 5.157

Review 3.  Spatial organization of RNA polymerase II transcription in the nucleus.

Authors:  M N Szentirmay; M Sawadogo
Journal:  Nucleic Acids Res       Date:  2000-05-15       Impact factor: 16.971

Review 4.  Phosphorylation in transcription: the CTD and more.

Authors:  T Riedl; J M Egly
Journal:  Gene Expr       Date:  2000

5.  Participation of the C-terminal domain of RNA polymerase II in exon definition during pre-mRNA splicing.

Authors:  C Zeng; S M Berget
Journal:  Mol Cell Biol       Date:  2000-11       Impact factor: 4.272

6.  Protein-interaction modules that organize nuclear function: FF domains of CA150 bind the phosphoCTD of RNA polymerase II.

Authors:  S M Carty; A C Goldstrohm; C Suñé; M A Garcia-Blanco; A L Greenleaf
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-01       Impact factor: 11.205

7.  Mature mRNAs accumulated in the nucleus are neither the molecules in transit to the cytoplasm nor constitute a stockpile for gene expression.

Authors:  D Weil; S Boutain; A Audibert; F Dautry
Journal:  RNA       Date:  2000-07       Impact factor: 4.942

8.  Systematic identification of novel protein domain families associated with nuclear functions.

Authors:  Tobias Doerks; Richard R Copley; Jörg Schultz; Chris P Ponting; Peer Bork
Journal:  Genome Res       Date:  2002-01       Impact factor: 9.043

9.  Capping, splicing, and 3' processing are independently stimulated by RNA polymerase II: different functions for different segments of the CTD.

Authors:  N Fong; D L Bentley
Journal:  Genes Dev       Date:  2001-07-15       Impact factor: 11.361

10.  Evolution of the RNA polymerase II C-terminal domain.

Authors:  John W Stiller; Benjamin D Hall
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-23       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.